Ming-Cheng Chen Selected Research

Ming-Cheng Chen Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 07/2011
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2013
8	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 02/2017
7	Colonic Neoplasms (Colon Cancer) 10/2021 - 07/2014
6	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2013
4	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2013
2	Osteosarcoma (Osteogenic Sarcoma) 08/2019 - 02/2018
2	Carcinogenesis 06/2018 - 01/2017
2	Mouth Neoplasms (Oral Cancer) 01/2017 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 01/2016
2	Rectal Neoplasms (Rectal Cancer) 07/2011 - 02/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2022
1	Adenocarcinoma of Lung 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Bacterial Infections (Bacterial Infection) 08/2020
1	Infections 01/2019
1	Disease Progression 01/2018
1	Heart Failure 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Inflammation (Inflammations) 07/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 07/2015
1	Sclerosis 07/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2015
1	Margins of Excision 07/2011
1	Enterocolitis 02/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2011
1	Intestinal Obstruction (Obstruction, Intestinal) 02/2011

Drug/Important Bio-Agent (IBA)

7	CateninsIBA 02/2017 - 01/2013
6	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2022 - 07/2014
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2021 - 07/2014
4	apicidinIBA 01/2021 - 01/2013
4	fisetinIBA 11/2020 - 01/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2022 - 01/2013
3	thymoquinoneIBA 02/2017 - 02/2015
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2019
2	Protein Phosphatase 1IBA 11/2020 - 06/2019
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 01/2017
2	taiwanin CIBA 01/2017 - 01/2017
2	Arecoline (Arecolin)IBA 01/2017 - 01/2017
1	Tannic Acid FDA Link 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022
1	CalreticulinIBA 01/2022
1	daidzeinIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	TriterpenesIBA 02/2021
1	SaponinsIBA 02/2021
1	platycodin DIBA 02/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021
1	human MIRN107 microRNAIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2021
1	VaccinesIBA 08/2020
1	Doxycycline (Periostat)FDA LinkGeneric 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Phosphotransferases (Kinase)IBA 10/2019
1	3-hydroxyflavoneIBA 08/2019
1	FlavonoidsIBA 06/2019
1	EugenolIBA 01/2019
1	jasmonic acid (jasmonate)IBA 01/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2019
1	anise oilIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 06/2018
1	lupeolIBA 05/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	PlatinumIBA 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	AntioxidantsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	regorafenibIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Dinoprostone (PGE2)FDA Link 02/2017
1	PhytochemicalsIBA 02/2017
1	Estrogens (Estrogen)FDA Link 02/2017
1	beta CateninIBA 01/2017
1	CarcinogensIBA 01/2017
1	Anthocyanins (Anthocyanin)IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	ResveratrolIBA 07/2015
1	CaspasesIBA 02/2015
1	ErbB Receptors (EGF Receptor)IBA 07/2014
1	NF-kappa B (NF-kB)IBA 07/2014
1	Topoisomerase I InhibitorsIBA 07/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2014
1	Serum AlbuminIBA 02/2011

Therapy/Procedure

8	Therapeutics 12/2022 - 02/2011
3	Drug Therapy (Chemotherapy) 01/2018 - 07/2014
1	Subcutaneous Injections 05/2020
1	Injections 05/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Operative Surgical Procedures 01/2014
1	Pelvic Exenteration 07/2011